Evidence map›Paper›PMID 38506728›Full record

ReviewThe Journal of cell biology2024

Crosstalk within and beyond the Polycomb repressive system.

Tianyi Hideyuki Shi, Hiroki Sugishita, Yukiko Gotoh

Open access · hybridAbstract readReview
In one paragraph

Review in The Journal of cell biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Epigenetic regulation of cancer stemness.Signal transduction and targeted therapy · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tianyi Hideyuki ShiGraduate School of Pharmaceutical Sciences, The University of Tokyo , Tokyo, Japan.ORCID 0000-0002-9204-9949
Hiroki SugishitaGraduate School of Pharmaceutical Sciences, The University of Tokyo , Tokyo, Japan.ORCID 0000-0002-6561-8261
Yukiko GotohGraduate School of Pharmaceutical Sciences, The University of Tokyo , Tokyo, Japan.ORCID 0000-0001-9367-6648
The University of Tokyo · JP

Funding

Collaborative Research in Engineering, Science and Technology Centre JP23gm1310004International Research Center for NeurointelligenceJapan Agency for Medical Research and Development JP23wm0525035Japan Society for the Promotion of Science JP22K15118Ministry of Education, Culture, Sports, Science, and Technology of JapanUehara Memorial FoundationUniversity of Tokyo
6 · The paper itself

Abstract

The development of multicellular organisms depends on spatiotemporally controlled differentiation of numerous cell types and their maintenance. To generate such diversity based on the invariant genetic information stored in DNA, epigenetic mechanisms, which are heritable changes in gene function that do not involve alterations to the underlying DNA sequence, are required to establish and maintain unique gene expression programs. Polycomb repressive complexes represent a paradigm of epigenetic regulation of developmentally regulated genes, and the roles of these complexes as well as the epigenetic marks they deposit, namely H3K27me3 and H2AK119ub, have been extensively studied. However, an emerging theme from recent studies is that not only the autonomous functions of the Polycomb repressive system, but also crosstalks of Polycomb with other epigenetic modifications, are important for gene regulation. In this review, we summarize how these crosstalk mechanisms have improved our understanding of Polycomb biology and how such knowledge could help with the design of cancer treatments that target the dysregulated epigenome.

Indexed as

Epigenetic RepressionGenes, DevelopmentalPolycomb-Group ProteinsAnimalsCell DifferentiationDrosophila ProteinsEpigenesis, GeneticHumansDrosophila ProteinsPolycomb-Group Proteins

Identifiers

PMID38506728
PMCPMC10955045
OpenAlexW4392994040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.